Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study
Tomoya Sano, Keisuke Amano, Tatsuya Ide, et al.
Hepatology Research (2023) Vol. 54, Iss. 4, pp. 326-335
Closed Access | Times Cited: 14

Showing 14 citing articles:

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu, et al.
Hepatology International (2025)
Closed Access | Times Cited: 5
Prevalence of Steatotic Liver Disease Based on a New Nomenclature in the Japanese Population: A Health Checkup-Based Cross-Sectional Study
Takao Miwa, Satoko Tajirika, Nanako Imamura, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 13
Editorial: Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus Infection
Nobuharu Tamaki, Masayuki Kurosaki
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study
Takashi Nishimura, Toshifumi Tada, Tomoyuki Akita, et al.
Journal of Gastroenterology (2025)
Open Access
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
Toru Nakamura, Atsutaka Masuda, Dan Nakano, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 428-428
Open Access
Evaluating the Effectiveness of Pegbelfermin in MASH‐Associated Hepatic Fibrosis A Meta‐Analysis and Systematic Review of Randomized Controlled Trials
Muhammad Shahzil, Fariha Hasan, Syeda Kanza Kazmi, et al.
JGH Open (2025) Vol. 9, Iss. 3
Open Access
Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 1023-1025
Open Access | Times Cited: 3
Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD
Chun‐Jen Liu, Wai Kay Seto, Ming‐Lung Yu
Hepatology International (2024) Vol. 18, Iss. S2, pp. 897-908
Closed Access | Times Cited: 3
Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan
Chung‐Feng Huang, Chia‐Yen Dai, Yi‐Hung Lin, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 883-894
Open Access | Times Cited: 3
MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors
Rex Wan‐Hin Hui, Lung‐Yi Mak
Clinical and Molecular Hepatology (2024) Vol. 31, Iss. 1, pp. 290-292
Open Access | Times Cited: 1
Association of metabolic dysfunction‐associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study
Masahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 6, pp. 1107-1114
Closed Access
Impact of MASLD on Portal Vein Thrombosis Following Hepatectomy for Liver Cancer
Yoshito Wada, Koji Okuda, Shin Sasaki, et al.
Cancers (2024) Vol. 16, Iss. 22, pp. 3844-3844
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management
Karina González-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda‐Granados, et al.
Clinics and Practice (2024) Vol. 14, Iss. 6, pp. 2542-2558
Open Access
Quantitative color analysis of the diets of patients with metabolic dysfunction‐associated steatotic liver disease: Comparative study with nutritionally balanced diets
Asumi Yamazaki, Yuka Takachi, Hirokazu Takahashi, et al.
Hepatology Research (2024)
Open Access
Page 1

Scroll to top